766 related articles for article (PubMed ID: 17557373)
21. Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency.
Lee JJ; Ozcan E; Rauter I; Geha RS
Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):520-6. PubMed ID: 18978466
[TBL] [Abstract][Full Text] [Related]
22. A proliferation-inducing ligand (APRIL) induced hyper-production of IgA from tonsillar mononuclear cells in patients with IgA nephropathy.
Takahara M; Nagato T; Nozaki Y; Kumai T; Katada A; Hayashi T; Harabuchi Y
Cell Immunol; 2019 Jul; 341():103925. PubMed ID: 31088610
[TBL] [Abstract][Full Text] [Related]
23. BAFF, APRIL and human B cell disorders.
Tangye SG; Bryant VL; Cuss AK; Good KL
Semin Immunol; 2006 Oct; 18(5):305-17. PubMed ID: 16916610
[TBL] [Abstract][Full Text] [Related]
24. The anti-apoptotic factor Bcl-2 can functionally substitute for the B cell survival but not for the marginal zone B cell differentiation activity of BAFF.
Tardivel A; Tinel A; Lens S; Steiner QG; Sauberli E; Wilson A; Mackay F; Rolink AG; Beermann F; Tschopp J; Schneider P
Eur J Immunol; 2004 Feb; 34(2):509-18. PubMed ID: 14768056
[TBL] [Abstract][Full Text] [Related]
25. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
26. The uncertain glory of APRIL.
Medema JP; Planelles-Carazo L; Hardenberg G; Hahne M
Cell Death Differ; 2003 Oct; 10(10):1121-5. PubMed ID: 14502235
[TBL] [Abstract][Full Text] [Related]
27. The role of APRIL and BAFF in lymphocyte activation.
Schneider P
Curr Opin Immunol; 2005 Jun; 17(3):282-9. PubMed ID: 15886118
[TBL] [Abstract][Full Text] [Related]
28. The BAFF/APRIL system: life beyond B lymphocytes.
Ng LG; Mackay CR; Mackay F
Mol Immunol; 2005 May; 42(7):763-72. PubMed ID: 15829264
[TBL] [Abstract][Full Text] [Related]
29. Activation and accumulation of B cells in TACI-deficient mice.
Yan M; Wang H; Chan B; Roose-Girma M; Erickson S; Baker T; Tumas D; Grewal IS; Dixit VM
Nat Immunol; 2001 Jul; 2(7):638-43. PubMed ID: 11429549
[TBL] [Abstract][Full Text] [Related]
30. Travelling with the BAFF/BLyS family: are we there yet?
Mackay F; Cancro MP
Semin Immunol; 2006 Oct; 18(5):261-2. PubMed ID: 16905331
[No Abstract] [Full Text] [Related]
31. Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome.
Daridon C; Devauchelle V; Hutin P; Le Berre R; Martins-Carvalho C; Bendaoud B; Dueymes M; Saraux A; Youinou P; Pers JO
Arthritis Rheum; 2007 Apr; 56(4):1134-44. PubMed ID: 17393395
[TBL] [Abstract][Full Text] [Related]
32. Suppressive effect of bacterial polysaccharides on BAFF system is responsible for their poor immunogenicity.
Kanswal S; Katsenelson N; Allman W; Uslu K; Blake MS; Akkoyunlu M
J Immunol; 2011 Feb; 186(4):2430-43. PubMed ID: 21248261
[TBL] [Abstract][Full Text] [Related]
33. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
Vollmer J; Weeratna RD; Jurk M; Davis HL; Schetter C; Wüllner M; Wader T; Liu M; Kritzler A; Krieg AM
J Leukoc Biol; 2004 Sep; 76(3):585-93. PubMed ID: 15218053
[TBL] [Abstract][Full Text] [Related]
34. Polymorphisms in genes of the BAFF/APRIL system may constitute risk factors of B-CLL--a preliminary study on a Polish population.
Jasek M; Wagner M; Sobczynski M; Wolowiec D; Kuliczkowski K; Woszczyk D; Kielbinski M; Kusnierczyk P; Frydecka I; Karabon L
Tissue Antigens; 2015 Oct; 86(4):279-84. PubMed ID: 26268376
[TBL] [Abstract][Full Text] [Related]
35. Toll-like receptor 9 activation enhances B cell activating factor and interleukin-21 induced anti-proteinase 3 autoantibody production in vitro.
Lepse N; Land J; Rutgers A; Kallenberg CG; Stegeman CA; Abdulahad WH; Heeringa P
Rheumatology (Oxford); 2016 Jan; 55(1):162-72. PubMed ID: 26320128
[TBL] [Abstract][Full Text] [Related]
36. TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts.
Bossen C; Cachero TG; Tardivel A; Ingold K; Willen L; Dobles M; Scott ML; Maquelin A; Belnoue E; Siegrist CA; Chevrier S; Acha-Orbea H; Leung H; Mackay F; Tschopp J; Schneider P
Blood; 2008 Feb; 111(3):1004-12. PubMed ID: 17942754
[TBL] [Abstract][Full Text] [Related]
37. TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells.
Treml LS; Carlesso G; Hoek KL; Stadanlick JE; Kambayashi T; Bram RJ; Cancro MP; Khan WN
J Immunol; 2007 Jun; 178(12):7531-9. PubMed ID: 17548587
[TBL] [Abstract][Full Text] [Related]
38. The role of the BAFF/APRIL system in the T cell-independent specific response to blood stage Plasmodium falciparum hemozoin.
Dechkajorn W; Benjathummarak S; Kumsiri R; Maneerat Y
Cytokine; 2018 Nov; 111():445-453. PubMed ID: 29884307
[TBL] [Abstract][Full Text] [Related]
39. TACI and BAFF-R mediate isotype switching in B cells.
Castigli E; Wilson SA; Scott S; Dedeoglu F; Xu S; Lam KP; Bram RJ; Jabara H; Geha RS
J Exp Med; 2005 Jan; 201(1):35-9. PubMed ID: 15630136
[TBL] [Abstract][Full Text] [Related]
40. BAFF binding to T cell-expressed BAFF-R costimulates T cell proliferation and alloresponses.
Ye Q; Wang L; Wells AD; Tao R; Han R; Davidson A; Scott ML; Hancock WW
Eur J Immunol; 2004 Oct; 34(10):2750-9. PubMed ID: 15368291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
